Appeal decision by eastern caribbean supreme court supports right of prime success and vivo capital to participate in critical sinovac biotech shareholder vote

Palo alto, calif.--(business wire)--vivo capital (“vivo” or “we”), a leading global investment firm focused exclusively on healthcare and life sciences and a long term shareholder of sinovac biotech ltd. (nasdaq:sva) (“sinovac” or the “company”), today announced that the court of appeals of the eastern caribbean supreme court granted a motion to stay the self-interested injunction sought and led by 1globe to prevent legitimate, long-term shareholders in the company from participating in its cri.
EML Ratings Summary
EML Quant Ranking